277804000: Symmetrical drug-related intertriginous and flexural exanthema (disorder)

SNOMED CT Concept\Clinical finding\...

\Hypersensitivity condition\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema

\Effect of exposure to physical force\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema

\Skin AND/OR mucosa finding\Skin finding\Disorder of skin\...

\Inflammatory dermatosis\Exogenous dermatitis\...

\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema

\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema

\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema

\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema

\Finding of limb structure\Disorder of extremity\Inflammatory disorder of extremity\Symmetrical drug-related intertriginous and flexural exanthema
\Finding of limb structure\Disorder of extremity\Disorder of lower extremity\Symmetrical drug-related intertriginous and flexural exanthema
\Finding of limb structure\Finding of lower limb\Disorder of lower extremity\Symmetrical drug-related intertriginous and flexural exanthema

\Finding of trunk structure\Finding of abdominopelvic segment of trunk\Disorder of abdominopelvic segment of trunk\Disorder of pelvic region of trunk\Symmetrical drug-related intertriginous and flexural exanthema
\Finding of trunk structure\Finding of abdominopelvic segment of trunk\Finding of pelvic region of trunk\Disorder of pelvic region of trunk\Symmetrical drug-related intertriginous and flexural exanthema
\Finding of trunk structure\Disorder of trunk\Disorder of abdominopelvic segment of trunk\Disorder of pelvic region of trunk\Symmetrical drug-related intertriginous and flexural exanthema

\General finding of soft tissue\Skin finding\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Skin finding\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Skin finding\Disorder of skin\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Skin finding\Disorder of skin\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema
\General finding of soft tissue\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema

\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Skin finding\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Skin finding\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Skin finding\Disorder of skin\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema
\Integumentary system finding\Skin finding\Disorder of skin\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema

\Disease\Disorder of body system\Inflammation of specific body systems\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Inflammation of specific body systems\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of body system\Disorder of integument\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of extremity\Inflammatory disorder of extremity\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of extremity\Disorder of lower extremity\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammatory disorder of extremity\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammation of specific body systems\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammation of specific body systems\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammation of specific body organs\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Inflammatory disorder\Inflammation of specific body structures or tissue\Inflammation of specific body organs\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of trunk\Disorder of abdominopelvic segment of trunk\Disorder of pelvic region of trunk\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Inflammation of skin and/or subcutaneous tissue\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Inflammatory dermatosis\Exogenous dermatitis\Contact dermatitis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Drug-induced dermatosis\Symmetrical drug-related intertriginous and flexural exanthema
\Disease\Disorder of soft tissue\Disorder of skin and/or subcutaneous tissue\Disorder of skin\Disorders of skin caused by physical agents\Intertrigo\Symmetrical drug-related intertriginous and flexural exanthema

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

414519015 Baboon syndrome en Synonym Active Entire term case insensitive SNOMED CT core module

4012984011 Symmetrical drug-related intertriginous and flexural exanthema en Synonym Active Entire term case insensitive SNOMED CT core module

4012985012 Symmetrical drug-related intertriginous and flexural exanthema (disorder) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Ingested allergen contact dermatitis	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Inflammation	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Finding site	Skin structure	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Eruption	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Causative agent	Allergen	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Causative agent	Chemical categorized by structure	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Finding site	Structure of immune system	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Papulovesicular rash	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Causative agent	Drug	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Has definitional manifestation	Immune system finding	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Due to	Allergic reaction	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Causative agent	Substance	false	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Due to	Immune hypersensitivity reaction	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Due to	Contact hypersensitivity reaction	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Chemical-induced dermatological disorder	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Due to	Immune hypersensitivity reaction	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Finding site	Skin structure	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Inflammation	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Allergic process	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Inflammation	false	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Finding site	Skin structure	true	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Hypersensitivity process	false	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Finding site	Skin structure	false	Inferred relationship	Existential restriction modifier	3
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Allergic process	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Non-immunoglobulin E-mediated allergic contact hypersensitivity process	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Inflammation of specific body organs	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Inflammatory morphology	false	Inferred relationship	Existential restriction modifier	3
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Non-immunoglobulin E-mediated allergic contact hypersensitivity process	false	Inferred relationship	Existential restriction modifier	3
Symmetrical drug-related intertriginous and flexural exanthema	Interprets	Itch of skin	false	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Contact dermatitis	true	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Contact hypersensitivity process	true	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Inflammatory morphology	true	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Drug-induced dermatosis	true	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Intertrigo	true	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Inflammatory disorder of extremity	true	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Finding site	Gluteal sulcus structure	true	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Causative agent	Friction	true	Inferred relationship	Existential restriction modifier	1
Symmetrical drug-related intertriginous and flexural exanthema	Associated morphology	Inflammatory morphology	true	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Pathological process	Contact hypersensitivity process	true	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Causative agent	Drug or medicament	true	Inferred relationship	Existential restriction modifier	2
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Disorder of lower extremity	true	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Disorder of abdominopelvic segment of trunk	false	Inferred relationship	Existential restriction modifier
Symmetrical drug-related intertriginous and flexural exanthema	Is a	Disorder of pelvic region of trunk	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Baboon syndrome caused by drug	Is a	False	Symmetrical drug-related intertriginous and flexural exanthema	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
414519015	Baboon syndrome	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
4012984011	Symmetrical drug-related intertriginous and flexural exanthema	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
4012985012	Symmetrical drug-related intertriginous and flexural exanthema (disorder)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module